|
|
|
|
Brand Name Manufacturers |
Aldactone by Searle |
|
Generic Manufacturers |
|
|
Pharmacology |
Mostly inhibits production of testosterone at the stage of 17-hydroxylation, and competes with DHT (dihydrotestosterone) for bonding at peripheral receptors. It is also said to intensify catabolism of androgens, and activate conversion of testosterone into estrogens. |
|
Delivery |
25, 50, 100mg oral tablets |
|
Typical dosage |
Pre-op 100-400mg/day |
|
Availability |
Approved by U.S. FDA |
|
Indications |
Congestive heart failure. Elevated blood pressure. Fluid retention. Hyperaldasteronism. Inadequate pottasium retention. Liver cirrhosis. |
|
Contraindications |
Elevated potassium levels. Inadequate urine production. Kidney disfunction. |
|
Adverse reactions |
CNS Confusion. Dizziness. Drowsiness. Headache. Lethargy. Loss of precise motor control. Gastrointestinal Cramping. Diarrhea. Dry mouth. Gastric ulceration and other stomach inflammation. Vomiting. Skin Acne. Itchy, fluid-filled patches of skin. Increase of body and facial hair. Red skin patches from capillary congestion. Other Deepening of the voice. Drug fever. Pottasium retention. Severe decrease of blood granulocytes. Sodium loss. |
|
Comments |
One person reported suicidal depression as an adverse effect. The brand-name formulation tastes awful; the generic formulation is much less offensive. |
bravenet.com